コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ycosylation provides a mechanism to modulate antibody avidity.
2 se residues contributing appreciable antigen-antibody avidity.
3 hich suffer from low sensitivity due to poor antibody avidity.
4 ation reaction has no deleterious effects on antibody avidity.
5 ults and explored immune memory by measuring antibody avidity.
6 titers < 1:4) and correlated with increasing antibody avidity.
7 .0 microg/mL following primary immunization, antibody avidity after booster was low, indicating an ab
8 vitro, apparently because of differences in antibody avidity and accessibility of the respective det
12 layed fractional dose increases CSP-specific antibody avidity and somatic hypermutation frequency in
13 e antigenic or undergo changes that increase antibody avidity, and how they can be altered to retain
14 e assessed by using the opsonophagocytic and antibody avidity assay against 8 serotypes and 23 seroty
15 ion of IgG that is HIV-specific, and with an antibody avidity assay based on the Genetic Systems 1/2+
16 We developed an HCV immunoglobulin G (IgG) antibody avidity assay by modifying the Ortho 3.0 HCV en
18 ED capture enzyme immunoassay (BED-CEIA), an antibody avidity assay, HIV load, and CD4(+) T-cell coun
21 that conferred protection had a higher mean antibody avidity constant (21.9 nM(-1)) than the 7 nonpr
23 tibody titer, conformational dependence, and antibody avidity during the first 6 to 10 months followi
24 ified a gender difference in postvaccination antibody avidity (female < male subjects) in adults <65
25 fragment phage-display library analysis, and antibody avidities for HA1 and HA2 domains were measured
26 n glomeruli, and iii) the impact of relative antibody avidity for dsDNA, chromatin fragments, or cros
27 This is the first study to show the role of antibody avidity for the HA1 globular head domain in red
31 cells, T-zone and GC B-dynamics, IgM and IgG antibodies, avidity maturation, and IC presentation by F
32 allenge dose with, if available, evidence of antibody avidity maturation or an hSBA titer of result >
33 omen assigned to TFV gel demonstrated slower antibody avidity maturation, as determined by the Bio-Ra
34 Such "conjugate vaccines" efficiently induce antibody avidity maturation, isotype switching, and immu
35 e topical TFV but became infected had slower antibody avidity maturation, with potential implications
39 mune responses against the tumor by altering antibody avidity or by enhancing innate immunity shifted
40 bly due to technique variation or changes in antibody avidity or titer or in cell panel composition.
41 CVI activities were directly correlated with antibody avidity, suggesting the importance of antibody
42 with an existing human herpesvirus 6 (HHV-6) antibody avidity test to detect and distinguish low-avid
43 svirus 7 (HHV-7) indirect immunofluorescence antibody avidity test was developed and used with an exi
45 boosting by the subcutaneous route increased antibody avidity to a greater extent than protein boosti
47 fic antibody epitope repertoire and enhanced antibody avidity to the HA1 (but not the HA2) domain in
48 d immunity (CMI), and immunoglobulin G (IgG) antibody avidity were assessed at baseline and 1 month a
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。